Skip to main content

Table 2 Clinicoparhological characteristics of patients with early-stage ovarian cancer

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Factor n %
Age   
<50 24 51.1
> = 50 23 48.9
Histology   
Serous/endometrioid 14 29.8
Mucinous/clear cell 33 70.2
Stage   
Ia/b 15 31.9
Ic/II 32 68.1